Intravitreal Brolucizumab for Choroidal Neovascularization Associated to Angioid Streaks
A 44-year-old-female with angioid streak- (AS-) associated choroidal-neovascularization (CNV) was treated with one dose of intravitreal brolucizumab (IB). At one-month, the patient’s visual acuity (VA) improved from 20/120 to 20/40 with a dry macula on spectral-domain optical-coherence tomography (S...
Saved in:
Main Authors: | Somnath Chakraborty, Jay Umed Sheth |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2022-01-01
|
Series: | Case Reports in Ophthalmological Medicine |
Online Access: | http://dx.doi.org/10.1155/2022/3442306 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Long-Term Effect of Anti-Vascular Endothelial Growth Factor (Anti-VEGF) Injections in Choroidal Neovascularization Secondary to Angioid Streaks
by: Sónia Torres-Costa, et al.
Published: (2022-01-01) -
Angioid streaks. A case report
by: Aimé Broche Hernández, et al.
Published: (2011-03-01) -
Role of Intravitreal Antivascular Endothelial Growth Factor Injections for Choroidal Neovascularization due to Choroidal Osteoma
by: Ahmad M. Mansour, et al.
Published: (2014-01-01) -
Changes in Aqueous Humor Cytokine Profile Following Intravitreal Brolucizumab Injection
by: Ruamviboonsuk V, et al.
Published: (2025-02-01) -
Management of Choroidal Neovascularization Associated with Optic Disc Melanocytoma with Intravitreal Aflibercept: A Case Report and Review of the Literature
by: Hany S. Hamza, et al.
Published: (2019-01-01)